TABLE OF CONTENTS
|  |  |  | Volume 23, Issue 1 (January 2016) |  | In this issue Original Articles Letter to the Editor
Also new    AOP | |  |  |  | | Advertisement |  | Open for Submissions
Molecular Therapy — Oncolytics is an online-only, open access journal, focusing on the development and clinical testing of viral, cellular, and other biological therapies targeting cancer.
Explore the benefits of submitting your next research article. |  | | | Original Articles | Top |  | Adenovirus-delivered wwox inhibited lung cancer growth in vivo in a mouse modelY Zhou, F Shou, H Zhang and Q You Cancer Gene Ther 2016 23: 1-6; advance online publication, October 30, 2015; 10.1038/cgt.2015.56 Abstract | Full Text |  |  |  | Using intron splicing trick for preferential gene expression in transduced cells: an approach for suicide gene therapyF Pourzadegan, L Shariati, R Taghizadeh, H Khanahmad, Z Mohammadi and M A Tabatabaiefar Cancer Gene Ther 2016 23: 7-12; advance online publication, December 18, 2015; 10.1038/cgt.2015.57 Abstract | Full Text |  |  |  | Synergistic tumor suppression by adenovirus-mediated ING4/PTEN double gene therapy for gastric cancerH Zhang, X Zhou, C Xu, J Yang, J Xiang, M Tao and Y Xie Cancer Gene Ther 2016 23: 13-23; advance online publication, November 13, 2015; 10.1038/cgt.2015.59 Abstract | Full Text |  |  |  | Gene therapy for ovarian cancer using carbonyl reductase 1 DNA with a polyamidoamine dendrimer in mouse modelsA Kobayashi, Y Yokoyama, Y Osawa, R Miura and H Mizunuma Cancer Gene Ther 2016 23: 24-28; advance online publication, November 20, 2015; 10.1038/cgt.2015.61 Abstract | Full Text |  |  |  | Blockage of miR-92a-3p with locked nucleic acid induces apoptosis and prevents cell proliferation in human acute megakaryoblastic leukemiaM Sharifi and R Salehi Cancer Gene Ther 2016 23: 29-35; advance online publication, December 11, 2015; 10.1038/cgt.2015.63 Abstract | Full Text |  |  |  | Inhibition of human telomerase reverse transcriptase in vivo and in vitro for retroviral vector-based antisense oligonucleotide therapy in ovarian cancerZ Qi and R Mi Cancer Gene Ther 2016 23: 36-42; advance online publication, January 8, 2016; 10.1038/cgt.2015.64 Abstract | Full Text |  | Letter to the Editor | Top |  | Chrysin and its emerging antineoplastic effectsE R Kasala, L N Bodduluru and C C Barua Cancer Gene Ther 2016 23: 43; 10.1038/cgt.2015.65 Full Text |  |  |  |  |  |  |  |  |  |  | Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.
Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com |  |  |  |  |  | |  | Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Cancer Gene Therapy. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. |  | | | | |
No comments:
Post a Comment